Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.22.2.2
Accrued Expenses
9 Months Ended
Sep. 30, 2022
Accrued Expenses [Abstract]  
ACCRUED EXPENSES

4 — ACCRUED EXPENSES

 

Accrued expenses consist of the following:

 

    September 30,
2022
    December 31,
2021
 
Clinical research organization services and expenses   $ 117,127     $ 1,826,479  
Employee compensation     686,501       520,795  
Preclinical and manufacturing expenses     119,839      
 
Legal and consulting services     31,938       29,656  
Total accrued expenses   $ 955,405     $ 2,376,930